CHU PHARMA's entire product line successfully passed the ISO 9001 international quality management system audit and certification, establishing standardized control procedures for the entire process from ra···

The company has completed its strategic expansion of its product portfolio, officially adding commonly used injectable APIs such as indocyanine green for injection, lidocaine hydrochloride, and gentamicin sulfa···

The 21st CPHI China Shanghai exhibition was successfully held. CHU PHARMA focused on the Middle East's essential pharmaceutical market, highlighting its sterile injectable APIs and oral formulation contract···

The 2020 Vietnam Ho Chi Minh City VIFA International Pharmaceutical Exhibition was successfully held, marking the company's first independent overseas participation in a professional pharmaceutical exhibiti···

CHU PHARMA and Shaanxi University of Science and Technology officially signed a long-term industry-university-research cooperation agreement. Leveraging the university's mature R&D capabilities in fine ···

Published: 2019-05-22 The 83rd API China (China International Pharmaceutical Ingredients Trade Fair) concluded successfully in Shanghai. This marked CHU PHARMA's first appearance at a major industry exhibit···

Recently, CHU PHARMA officially completed its business registration in Xi'an. The company focuses on "high-quality API export, customized CDMO API manufacturing, and injectable OEM production," ba···